Analyst ratings, especially from reputable firms like Mizuho, can significantly influence investor sentiment and stock prices. A Buy rating combined with a substantial price target suggests a strong bullish outlook for Enliven Therapeutics, likely leading to increased investor interest and potentially higher stock prices in the short term.